Stymied by the pan­dem­ic, Im­munomedic­s' new CEO bows out, tak­ing a mil­lion bucks plus perks as he heads out the vir­tu­al ex­it

Just a lit­tle more than a month since tak­ing over as the lat­est CEO to helm Im­munomedics, $IM­MU Harout Se­mer­jian is ex­it­ing the com­pa­ny af­ter be­ing con­front­ed by “lo­gis­ti­cal” ob­sta­cles thrown up by the pan­dem­ic that made it im­pos­si­ble for him to move from Lon­don to car­ry out the job. And he’s get­ting a lit­tle over a mil­lion dol­lars in cash plus perks to grease the skids on the way out.

Word of the change­up ar­rived right af­ter the mar­ket closed Wednes­day.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER